Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. company information, Employees & Contact Information

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth. See our community guidelines: http://acor.bio/acordasocial

Company Details

Employees
182
Founded
-
Address
2 Blue Hill Plaza, 3rd Fl,united States
Phone
(914) 347-4300
Email
in****@****rda.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
acorda.com
HQ
Pearl River, New York
Looking for a particular Acorda Therapeutics, Inc. employee's phone or email?

Acorda Therapeutics, Inc. Questions

News

Acorda Therapeutics Announces Delisting from Nasdaq - Business Wire

Acorda Therapeutics Announces Delisting from Nasdaq Business Wire

Benjamin Acorda takes oath as PAOCC executive director - GMA Network

Benjamin Acorda takes oath as PAOCC executive director GMA Network

Dream Pop Act Megumi Acorda’s ‘Unexpectedly’ Still Shines Seven Years Later - Rolling Stone Philippines

Dream Pop Act Megumi Acorda’s ‘Unexpectedly’ Still Shines Seven Years Later Rolling Stone Philippines

Ex-PNP chief Acorda named as PAOCC executive director - GMA Network

Ex-PNP chief Acorda named as PAOCC executive director GMA Network

Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. - Biogen

Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. Biogen

Acorda Therapeutics to Present INBRIJA® Data at the American Academy of Neurology Annual Meeting - Stock Titan

Acorda Therapeutics to Present INBRIJA® Data at the American Academy of Neurology Annual Meeting Stock Titan

Acorda files for bankruptcy, reveals asset sale plan - BioPharma Dive

Acorda files for bankruptcy, reveals asset sale plan BioPharma Dive

UPDATED: Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales - Fierce Pharma

UPDATED: Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales Fierce Pharma

Company Discontinues Development of Plumiaz Nasal Spray - Medical Professionals Reference

Company Discontinues Development of Plumiaz Nasal Spray Medical Professionals Reference

Acorda Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire

Acorda Therapeutics Reports Third Quarter 2023 Financial Results Business Wire

Acorda To Present At The J.P. Morgan Conference; Webcast At 12:45 PM ET - RTTNews

Acorda To Present At The J.P. Morgan Conference; Webcast At 12:45 PM ET RTTNews

Byram Hills Students Win Acorda Awards - Patch

Byram Hills Students Win Acorda Awards Patch

Acorda dumps $363M Parkinson’s drug after patient deaths - Fierce Biotech

Acorda dumps $363M Parkinson’s drug after patient deaths Fierce Biotech

Generic Dalfampridine Tablet Marketed for Patients With MS - Pharmacy Times

Generic Dalfampridine Tablet Marketed for Patients With MS Pharmacy Times

Megumi Acorda Are Taking Success One Gig At A Time - Billboard Philippines

Megumi Acorda Are Taking Success One Gig At A Time Billboard Philippines

Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda - Fierce Pharma

Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda Fierce Pharma

Ampyra approved to improve walking in multiple sclerosis patients - Medical Professionals Reference

Ampyra approved to improve walking in multiple sclerosis patients Medical Professionals Reference

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 - Business Wire

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 Business Wire

How Megumi Acorda Went From Solo Project To Indie Supergroup - Billboard Philippines

How Megumi Acorda Went From Solo Project To Indie Supergroup Billboard Philippines

Acorda retires from PNP after 3 months of extended service - Inquirer.net

Acorda retires from PNP after 3 months of extended service Inquirer.net

Cruz out, Acorda in: Marcos revamps anti-organized crime commission - Rappler

Cruz out, Acorda in: Marcos revamps anti-organized crime commission Rappler

Retired PNP chief Acorda: I did my best - Inquirer.net

Retired PNP chief Acorda: I did my best Inquirer.net

Getting to know new PNP chief Maj. Gen. Benjamin Acorda Jr. - Inquirer.net

Getting to know new PNP chief Maj. Gen. Benjamin Acorda Jr. Inquirer.net

Ex-PNP chief Acorda seen with alleged POGO players - Philstar.com

Ex-PNP chief Acorda seen with alleged POGO players Philstar.com

Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Other Events - marketexclusive.com

Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Other Events marketexclusive.com

Top Acorda Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant